These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Guideline will aid early detection of familial hypercholesterolaemia. Savill P Practitioner; 2008 Oct; 252(1711):30, 32-3. PubMed ID: 18972797 [No Abstract] [Full Text] [Related]
43. Importance of early recognition of heterozygous familial hypercholesterolaemia. Ryan A; Byrne CD Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611 [TBL] [Abstract][Full Text] [Related]
45. [Application of gene technology in the diagnosis of familial hypercholesterolemia]. Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960 [TBL] [Abstract][Full Text] [Related]
46. Individuals' experiences of, and responses to, a negative genetic test result for familial hypercholesterolaemia. Hilgart J; Mercer J; Thirlaway K J Health Psychol; 2013 Mar; 18(3):339-49. PubMed ID: 22517949 [TBL] [Abstract][Full Text] [Related]
47. Manifestations of familial hypercholesterolaemia. Gillett MJ; Burnett JR Intern Med J; 2005 Jan; 35(1):63-4. PubMed ID: 15667473 [No Abstract] [Full Text] [Related]
48. [Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians]. ten Asbroek AH; van Lunsen S; Marang-van de Mheen PJ; Gunning-Schepers LJ Ned Tijdschr Geneeskd; 2000 Jan; 144(3):125-9. PubMed ID: 10674119 [TBL] [Abstract][Full Text] [Related]
49. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology. Safarova MS; Kullo IJ Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842 [No Abstract] [Full Text] [Related]
50. Diagnosis of familial hypercholesterolaemia using DNA probes for the low-density lipoprotein (LDL) receptor gene. Armston AE; Iversen SA; Burke JF Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():142-9. PubMed ID: 2898232 [TBL] [Abstract][Full Text] [Related]
51. Genetic testing in familial hypercholesterolaemia: What does it add? Banach M; Penson PE Eur J Prev Cardiol; 2020 Jan; 27(1):105-106. PubMed ID: 31408367 [No Abstract] [Full Text] [Related]
52. Can patients be accurately assessed for familial hypercholesterolaemia in primary care? Bell DA; Kirke AB; Barbour R; Southwell L; Pang J; Burrows S; Watts GF Heart Lung Circ; 2014 Dec; 23(12):1153-7. PubMed ID: 25065543 [TBL] [Abstract][Full Text] [Related]
54. Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: a longitudinal study among participants. van Maarle MC; Stouthard ME; Bonsel GJ J Med Genet; 2003 Jan; 40(1):e3. PubMed ID: 12525551 [No Abstract] [Full Text] [Related]
55. Improving the yield of genetic testing in familial hypercholesterolaemia. Ajufo E; Cuchel M Eur Heart J; 2017 Feb; 38(8):574-576. PubMed ID: 27161618 [No Abstract] [Full Text] [Related]
56. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations. Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772 [TBL] [Abstract][Full Text] [Related]
57. Familial Hypercholesterolaemia in the Era of Genetic Testing. Hughes DP; Viljoen A; Wierzbicki AS Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618 [TBL] [Abstract][Full Text] [Related]